Interpace Biosciences, Inc. Stock
Stocks
IDXG
US46062X3035
Healthcare Facilities & Services
OTC Markets Traded|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.790 USD | +2.29% |
|
+17.38% | +45.50% |
| Market Cap | 40.44M 35.51M 33.03M 30.31M 56.97M 3.9B 57.83M 392M 153M 1.91B 152M 149M 6.62B | P/E 2024 |
6.84x | P/E 2025 | 1.39x |
|---|---|---|---|---|---|
| Enterprise Value | 39.12M 34.35M 31.95M 29.32M 55.11M 3.78B 55.94M 379M 148M 1.85B 147M 144M 6.4B | EV / Sales 2024 |
0.35x | EV / Sales 2025 | 0.11x |
| Free-Float |
14.74% | Yield 2024 * |
-
| Yield 2025 | - |
| 1 day | +2.29% | ||
| 1 week | +17.38% | ||
| Current month | +9.82% | ||
| 1 month | +9.15% | ||
| 3 months | -9.37% | ||
| 6 months | +3.47% | ||
| Current year | +45.50% |
| 1 week | 1.34 | 1.79 | |
| 1 month | 1.34 | 1.8 | |
| Current year | 1.03 | 2.4 | |
| 1 year | 0.77 | 2.4 | |
| 3 years | 0.44 | 3.54 | |
| 5 years | 0.44 | 10.33 | |
| 10 years | 0.44 | 198 |
| Manager | Title | Age | Since |
|---|---|---|---|
Thomas Burnell
CEO | Chief Executive Officer | 64 | 2020-11-30 |
| Director of Finance/CFO | 34 | 2023-04-20 | |
Nicole Massoll
CTO | Chief Tech/Sci/R&D Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
Stephen Sullivan
CHM | Chairman | 79 | 2016-06-20 |
Joseph Keegan
BRD | Director/Board Member | 73 | 2015-12-31 |
Fortunato Rocca
BRD | Director/Board Member | 64 | 2020-01-21 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 1/20/26 | 1315 Capital LLC
| Conversion | Company | 9,405,941 | 212.3938% | |
| 1/20/26 | Ampersand Management LLC
| Conversion | Company | 13,861,386 | 313.0013% | |
| 2/1/24 | Free | Chief Financial Officer | 10,000 | 0.2314% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +2.29% | +17.38% | +98.87% | -8.67% | 40.44M | ||
| -1.02% | -3.46% | +88.62% | +456.36% | 37.52B | ||
| +1.98% | +4.73% | +12.01% | +33.86% | 24.34B | ||
| +2.02% | -3.02% | -24.40% | -39.44% | 7.33B | ||
| +0.97% | -1.00% | +7.25% | +82.27% | 4.84B | ||
| +4.27% | +4.26% | +14.34% | +47.64% | 3.05B | ||
| -2.46% | -4.93% | +120.83% | -16.53% | 1.81B | ||
| -2.07% | -1.52% | -14.29% | -63.84% | 1.78B | ||
| -6.75% | -6.90% | -25.97% | +695.42% | 1.75B | ||
| +5.58% | -1.99% | +12.29% | +2.91% | 1.74B | ||
| Average | +0.48% | -1.50% | +28.95% | +119.00% | 8.42B | |
| Weighted average by Cap. | +0.38% | -0.69% | +43.82% | +229.00% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 46.93M 41.2M 38.32M 35.16M 66.1M 4.53B 67.1M 454M 178M 2.22B 176M 172M 7.68B | 38.73M 34M 31.63M 29.02M 54.55M 3.74B 55.38M 375M 147M 1.83B 145M 142M 6.34B |
| Net income | 6.7M 5.88M 5.47M 5.02M 9.44M 647M 9.58M 64.91M 25.39M 317M 25.15M 24.61M 1.1B | 24.58M 21.58M 20.07M 18.42M 34.62M 2.37B 35.14M 238M 93.1M 1.16B 92.22M 90.26M 4.02B |
| Net Debt | 4.4M 3.86M 3.59M 3.29M 6.19M 424M 6.28M 42.56M 16.65M 208M 16.49M 16.14M 719M | -1.32M -1.16M -1.08M -991K -1.86M -128M -1.89M -12.8M -5.01M -62.55M -4.96M -4.86M -216M |
Employees
102
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-07-24 | $1.460 | +0.69% | 4,002 |
| 26-07-23 | $1.450 | -3.97% | 2,536 |
| 26-07-22 | $1.510 | +0.37% | 4,632 |
| 26-07-21 | $1.504 | +0.97% | 1,217 |
| 26-07-20 | $1.490 | -2.30% | 4,423 |
Annual profits - Rate of surprise
- Stock Market
- Stocks
- IDXG Stock
Select your edition
All financial news and data tailored to specific country editions
















